APPILI THERAPEUTICS
Appili Therapeutics is an anti-infective pharmaceutical development company. Our approach lies in matching unmet medical needs with opportunities for more effective solutions that range from improvements in established therapies to entirely new classes of anti-infectives.
APPILI THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2015-01-01
Address:
Halifax, Nova Scotia, Canada
Country:
Canada
Website Url:
http://www.appilitherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
(902)442-4655
Email Addresses:
[email protected]
Total Funding:
63.58 M USD
Technology used in webpage:
Google Maps Person Schema Gravatar Profiles U.S. Server Location
Similar Organizations
APCBio Innovations
APCBio Innovations is a biopharmaceutical product development company.
Arkuda Therapeutics
Arkuda Therapeutics is a pharmaceutical company.
Blade Therapeutics
Blade Therapeutics is a discovery stage drug development company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
SAB Biotherapeutics
SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.
Current Employees Featured
Founder
Stock Details
Investors List
Bloom Burton & Co.
Bloom Burton & Co. investment in Post-IPO Debt - Appili Therapeutics
Bloom Burton & Co.
Bloom Burton & Co. investment in Post-IPO Debt - Appili Therapeutics
Long Zone Holdings
Long Zone Holdings investment in Post-IPO Debt - Appili Therapeutics
Defense Threat Reduction Agency (DTRA)
Defense Threat Reduction Agency (DTRA) investment in Grant - Appili Therapeutics
FUJIFILM Toyama
FUJIFILM Toyama investment in Post-IPO Equity - Appili Therapeutics
The Lind Partners
The Lind Partners investment in Post-IPO Debt - Appili Therapeutics
Industrial Alliance Securities
Industrial Alliance Securities investment in Post-IPO Equity - Appili Therapeutics
Haywood Securities Inc.
Haywood Securities Inc. investment in Post-IPO Equity - Appili Therapeutics
Research Capital Corporation
Research Capital Corporation investment in Post-IPO Equity - Appili Therapeutics
Richardson GMP
Richardson GMP investment in Post-IPO Equity - Appili Therapeutics
Key Employee Changes
Official Site Inspections
http://www.appilitherapeutics.com Semrush global rank: 7.77 M Semrush visits lastest month: 717
- Host name: 195.241.167.72.host.secureserver.net
- IP address: 72.167.241.195
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Appili Therapeutics"
About us - Appili Therapeutics
ABOUT US Overview ABOUT US Matching Novel Drug Development Programs With Clearly Defined Patient Needs in Infectious Disease Appili Therapeutics Inc., was founded in 2015 by …See details»
Board of Directors - Appili Therapeutics
He currently serves as Chief Business Officer of Tailored Genes, a viral vector development and manufacturing organization, where he leads corporate development initiatives. Previously, Mr. …See details»
Appili Therapeutics - Crunchbase Company Profile & Funding
Organization. Appili Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Contact Email …See details»
Appili Therapeutics - LinkedIn
Appili Therapeutics is an infectious disease biopharmaceutical company that is purposefully built, portfolio-driven, and people-focused to fulfill its mission of solving life-threatening infections.See details»
Appili Therapeutics Company Description - Stock Analysis
Dec 6, 2024 Company profile for Appili Therapeutics Inc. (TSX: APLI) with a description, list of executives, contact details and other key facts.See details»
Company Appili Therapeutics Inc. - MarketScreener.com
May 6, 2015 Appili Therapeutics Inc.: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Toronto S.E.: APLI ...See details»
Appili Therapeutics - Overview, News & Similar companies
Apr 2, 2024 Popular Searches Appili Therapeutics Inc Appili Therapeutics Appili Therapeutics - Inc Appilitherapeutics Ati-1501 SIC Code 87,873 NAICS Code 54,541 Ticker OTC: APLIF …See details»
Appili Therapeutics - Products, Competitors, Financials, Employees ...
About Appili Therapeutics. Appili Therapeutics is a biopharmaceutical company focused on the development of treatments for infectious diseases. The company's main offerings include …See details»
Appili Therapeutics Announces Results of Annual and Special
Sep 17, 2024 For more information, visit www.AppiliTherapeutics.com. Media Contact: Jenna McNeil, Corporate Affairs and Communications Manager Appili Therapeutics E: …See details»
Highlights - Appili Therapeutics
Investors Highlights APPILI THERAPEUTICS In The Global Race Against Infectious Diseases Internal Innovation; Active In-Licensing. Appili Therapeutics is proud to be at the forefront of …See details»
Appili Therapeutics Presents Update on ATI-1701 Biodefense
Oct 17, 2024 To request a meeting with Appili, please contact [email protected]. About ATI-1701 ATI-1701 is a novel, live-attenuated vaccine for F. tularensis , which causes …See details»
Appili Therapeutics Announces Alignment with FDA on …
Oct 31, 2024 For more information, visit www.AppiliTherapeutics.com. Forward Looking Statements This news release contains “forward-looking statements”, including with respect to …See details»
Aditxt’s Acquisition Target Appili Therapeutics Will Hold a Special ...
Oct 10, 2024 MOUNTAIN VIEW, Calif., October 10, 2024--Aditxt, Inc. ("Aditxt" or the "Company") (NASDAQ: ADTX), an innovation platform dedicated to accelerating promising …See details»
Appili Therapeutics Reports Financial and Operational Results for …
Aug 11, 2023 FDA established a PDUFA action date for ATI-1501 of September 23, 2023. Government funding committed to enable Appili to advance its biodefense vaccine candidate …See details»
News - Appili Therapeutics
Nov 14, 2024 [email protected] Get in Touch NEWS NEWS 2024 NEWS NEWS 2024 News Highlights Check this page for recent news from Appili Therapeutics. Members of …See details»
Appili Therapeutics - Craft
Appili Therapeutics has 5 employees across 2 locations and $16.3 m in total funding,. See insights on Appili Therapeutics including office locations, competitors, revenue, financials, …See details»
Appili Therapeutics TSX:APLI Stock Report - Simply Wall St
3 days ago appilitherapeutics.com: Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in infectious …See details»
Pipeline - Appili Therapeutics
PIPELINE Overview Diversified Pipeline Driving Near- And Long-Term Value Through Appili’s unique approach to drug development, we have created a pipeline containing a deliberate mix …See details»
Career Opportunities - Appili Therapeutics
Headquarters 21-1344 Summer St, Halifax, NS, B3H 0A8 USA Office 5100 Buckeystown Pike #250, Frederick MD, 21704See details»